[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:vwf-inhibitor":3},{"name":4,"total":5,"recruiting":5,"trials":6},"VWF inhibitor",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06998524","A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease",[11],"Phase 3","RECRUITING","2026-08-26T02:17:19.710918Z","2026-05-05T02:43:29.366334Z"]